The American Academy of Pediatrics (AAP) has published a policy statement approving the Recommended Childhood and Adolescent Immunization Schedule: United States 2022.

The 2022 Recommended Childhood and Adolescent Immunization Schedule has also been approved by the Centers for Disease Control and Prevention (CDC), American Academy of Pediatrics, American Academy of Family Physicians, American College of Obstetricians and Gynecologists, American College of Nurse-Midwives, American Academy of Physician Assistants and National Association of Pediatric Nurse Practitioners. The schedules are revised annually, reflecting recommendations for the use of vaccines licensed by the U.S. Food and Drug Administration (FDA).

This year, the schedule has been updated to closely reflect the formatting of adult immunization schedules — to ensure consistency. Like the 2021 schedule, the cover page includes an alphabetical listing of vaccines, their approved abbreviations and trade names.

The format of the schedule is split up into three tables:

Table 1 contains the recommended immunization schedule from birth to 18 years of age.
Table 2 is the catch-up immunization schedule for infants 4 months of age to 18 years who start their immunizations late or are more than one month behind the recommended age for vaccine administration.
Table 3 lists the vaccines that may be indicated for children and adolescents that are 18 years of age or younger on the basis of medical conditions.

2022 immunization schedule updates

Like the 2021 schedule, the footnotes are presented in alphabetical order. The following notes have been updated in the 2022 schedule:

The text in the “additional information” of the COVID-19 vaccine section has been updated.
A new section has been added that contains information regarding routine recommendation for use of dengue vaccine.
Text has been edited to include recommendations for use of Vaxelis for routine and catch-up vaccinations for the Haemophilus influenzae tybe b (Hib) vaccination.
The age for routine vaccination of hepatitis A has been clarified.

Learn more about other updates to the 2022 immunizations schedule.

The note has been updated to clarify when the human papillomavirus vaccination (HPV) series is complete, and no additional dose is recommended. In addition, the Special Situations section was updated to clarify that anyone with immunocompromising conditions (like HIV infections) should receive three doses of the HPV vaccine, regardless of age at the initial vaccination.
The section on routine vaccination was updated to include recommendations for the use of the combination measles, mumps, rubella, and varicella vaccine (MMRV).
For meningococcal serogroup A, C, W, and Y vaccines (MenACWY), text was added to clarify MenACWY vaccines can be simultaneously administered with serogroup B meningococcal (MenB) vaccines if indicated but at different anatomic sites. In addition, in the Special Situations section, the language for the dosing schedule for Menveo in infants was edited for clarity.